Substantial Attributable Risk Related to a Functional Mu-opioid Receptor Gene Polymorphism in Association with Heroin Addiction in Central Sweden

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2004 Mar 24

PMID 15037869

Citations 82

Authors

G Bart

M Heilig

K S LaForge

L Pollak

S M Leal

J Ott

M J Kreek

Affiliations

Soon will be listed here.

Citing Articles

Molecular and Environmental Determinants of Addictive Substances.

Lorek M, Kaminski P, Baszynski J, Tadrowski T, Gorzelanczyk E, Feit J Biomolecules. 2024; 14(11).

PMID: 39595582 PMC: 11592269. DOI: 10.3390/biom14111406.

Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments.

Barrett J, Shekarabi A, Inan S Pharmacol Rev. 2023; 75(6):1062-1118.

PMID: 37321860 PMC: 10595024. DOI: 10.1124/pharmrev.121.000506.

Genetic and epigenetic studies of opioid abuse disorder - the potential for future diagnostics.

Abdulmalek S, Hardiman G Expert Rev Mol Diagn. 2023; 23(5):361-373.

PMID: 37078260 PMC: 10257799. DOI: 10.1080/14737159.2023.2190022.

Investigating the potential of mirtazapine to induce drug-seeking behavior in free-choice drinking mouse model.

Althobaiti Y Saudi Pharm J. 2023; 30(12):1809-1815.

PMID: 36601513 PMC: 9805978. DOI: 10.1016/j.jsps.2022.10.010.

Pharmacogenetics of Addiction Therapy.

Graham D, Harding M, Nielsen D Methods Mol Biol. 2022; 2547:437-490.

PMID: 36068473 DOI: 10.1007/978-1-0716-2573-6_16.

References

Tsuang M, Lyons M, Meyer J, Doyle T, Eisen S, Goldberg J . Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 1998; 55(11):967-72. DOI: 10.1001/archpsyc.55.11.967. View

Belknap J, Crabbe J . Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice. Ann N Y Acad Sci. 1992; 654:311-23. DOI: 10.1111/j.1749-6632.1992.tb25977.x. View

Becker A, Grecksch G, Brodemann R, Kraus J, Peters B, Schroeder H . Morphine self-administration in mu-opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol. 2000; 361(6):584-9. DOI: 10.1007/s002100000244. View

Bond C, LaForge K, Tian M, Melia D, Zhang S, Borg L . Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998; 95(16):9608-13. PMC: 21386. DOI: 10.1073/pnas.95.16.9608. View

Kreek M, LaForge K, Butelman E . Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002; 1(9):710-26. DOI: 10.1038/nrd897. View

Oslin D, Berrettini W, Kranzler H, Pettinati H, Gelernter J, Volpicelli J . A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology. 2003; 28(8):1546-52. DOI: 10.1038/sj.npp.1300219. View

Hernandez-Avila C, Wand G, Luo X, Gelernter J, Kranzler H . Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet. 2003; 118B(1):60-5. DOI: 10.1002/ajmg.b.10054. View

Matthes H, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I . Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996; 383(6603):819-23. DOI: 10.1038/383819a0. View

LaForge K, Yuferov V, Kreek M . Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol. 2001; 410(2-3):249-268. DOI: 10.1016/s0014-2999(00)00819-0. View

10.

Wand G, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S . The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology. 2001; 26(1):106-14. DOI: 10.1016/S0893-133X(01)00294-9. View